Article Commentary: Fundamental Problems Lie Ahead in the Drug Discovery and Commercialization Process: Restructuring of the Pharmaceutical Industry and an Improved Partnership with Academia are Required

Horrobin DF. Innovation in the pharmaceutical industry. J R Soc Med 2000;93:341–5.

Surviving the blockbuster syndrome . Science 2004;3031796–99.

Lahana R. How many leads from Hts? Drug Discov Today 1999;4:447–8.

Fewer drugs and biologics advancing from phase I trials to marketplace. J Invest Med 2004;52434–5.

When pharma merges, R&D is the dowry. Science 2000;2871952.

Zeitlin PL. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest 1999;103:447–52.

About Nord. Available at: http://www.rarediseases.org/info/about.html (accessed April 19, 2005).

Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House; 2004.

Kassirer JP. On the take: how America's complicity with big business can endanger your health. New York: Oxford University Press; 2005.

Brewer GJ , Hedera P , Kluin KJ , . Treatment of Wilson disease with ammonium tetrathiomolybdate: III. initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 2003;60:379–85.

Brewer GJ , Ullenbruch MR , Dick RB , . Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. J Lab Clin Med 2003;141:210–6.

Brewer GJ , Dick R , Ullenbruch MR , . Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis. J Inorg Biochem 2004;98:2160–7.

Askari FK , Dick RB , Mao M , . Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice. Exp Biol Med 2004;229:857–63.

Ma S , Hou G , Dick RD , . Tetrathiomolybdate protects against liver injury from acetaminophen in mice. J Appl Res Clin Exp Ther 2004;4:419–26.

Hou G , Dick R , Abrams GD , . Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice. J Lab Clin Med 2006;146:299–303.

Zemlo TR , Garrison HH , Partridge NC , . The physician-scientist: career issues and challenges at the year 2000. FASEB J 2000;14:221–30.

Bloom FE. Presidential address. Science as a way of life: perplexities of a physician-scientist. Science 2003;300:1680–5.

Sung NS , Crowley WF , Genel M , . Central challenges facing the national clinical research enterprise. JAMA 2003;289:1278–87.

Rosenberg RN. Translating biomedical research to the bedside: a national crisis and a call to action. JAMA 2003;289:1305–6.

Clinical Research Enhancement Act passes Senate, moves on to House. J Invest Med 2000;4888–9.

Ruth L , Kirschstein MD , [interview]. J Invest Med 2001;49467–8.

Financial incentive for young clinical researchers: loan repayment programs, public and private. J Invest Med 2001;49:473–4.

Gallin EK , Le Blancq SM. Launching a new fellowship for medical students: the first years of the Doris Duke Clinical Research Fellowship Program. J Invest Med 2005;53:73–81.

Brewer GJ. Crises in academic medicine. Exp Biol Med 2001;226:239–42.

Marshall E , Couzin J. Millennium downsized. Science 2003;300:1637.